Oragenics (NYSEAMERICAN:OGEN) Stock Price Down 1.5% – Here’s Why

Oragenics, Inc. (NYSEAMERICAN:OGEN) dropped 1.5% on Monday . The company traded as low as $0.54 and last traded at $0.5411. 8,676 shares traded hands during trading, a decline of 72% from the average daily volume of 30,866 shares. The stock had previously closed at $0.5496.

Oragenics Trading Down 1.5%

The company has a market capitalization of $2.44 million, a PE ratio of -0.03 and a beta of 1.25. The company has a fifty day simple moving average of $0.59 and a 200-day simple moving average of $0.69.

Oragenics (NYSEAMERICAN:OGEN) last posted its quarterly earnings results on Friday, May 8th. The company reported ($0.51) EPS for the quarter.

Institutional Investors Weigh In On Oragenics

Several hedge funds and other institutional investors have recently bought and sold shares of OGEN. XTX Topco Ltd acquired a new position in Oragenics in the 4th quarter valued at about $26,000. Bank of America Corp DE grew its stake in shares of Oragenics by 7,374.0% in the 2nd quarter. Bank of America Corp DE now owns 15,546 shares of the company’s stock valued at $59,000 after buying an additional 15,338 shares during the period. Finally, DRW Securities LLC increased its holdings in shares of Oragenics by 82.4% during the 4th quarter. DRW Securities LLC now owns 112,709 shares of the company’s stock worth $88,000 after buying an additional 50,900 shares during the last quarter. 18.71% of the stock is currently owned by institutional investors and hedge funds.

About Oragenics

Oragenics, Inc is a clinical-stage biotechnology company focused on the research and development of novel anti-infective therapeutics targeting oral and mucosal diseases. Headquartered in Tampa, Florida, the company leverages proprietary technologies to address unmet needs in dental and oral healthcare, with an emphasis on innovative treatments that can improve patient outcomes and reduce reliance on traditional antibiotics.

The company’s lead product candidate, Oraprev™, is being developed as a pre-procedural rinse designed to reduce oral microbial load prior to dental procedures.